Association between comorbidities and dementia in diabetes mellitus patients: Population-based retrospective cohort study

Journal of Diabetes and its Complications

Volumn 29, Issue 8, 2015, Pages 1071-1076

  Kuo, Shu Chen ^a,f   Lai, Shih Wei ^c,d   Hung, Hung Chang ^b   Muo, Chih Hsin ^d   Hung, Shih Chang ^b   Liu, Ling Ling ^b   Chang, Chia Wei ^b   Hwu, Yueh Juen ^e   Chen, Shieh Liang ^f   Sung, Fung Chung ^d,g  

^a Lo Sheng Sanatorium and Hospital Ministry of Health and Welfare   (Taiwan)

^b Nantou Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Comorbidity; Dementia; Epidemiology; Retrospective cohort; Risk

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMENTIA; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AGE; CHEMICALLY INDUCED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORD; KAPLAN MEIER METHOD; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PUBLIC HEALTH; RISK FACTOR; TAIWAN;

AGE FACTORS; COHORT STUDIES; COMORBIDITY; DEMENTIA; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84948710628     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.06.010     Document Type: Article

References (40)

1. A.M. Adelman, and M.P. Daly Initial evaluation of the patient with suspected dementia American Family Physician 71 9 2005 1745 1750
2. L. Apostolova, S. DeKosky, and J. Cummings Dementias R.B. Daroff, G.M. Fenichel, J. Jankovic, J.C. Mazziotta, Bradley's Neurology in Clinical Practice Vol. 2 2012 Saunders Philadelphia 1534 1582
3. W.A. Banks, J.B. Owen, and M.A. Erickson Insulin in the brain: there and back again Pharmacology and Therapeutics 136 1 2012 82 93
4. K.Y. Chan, W. Wang, J.J. Wu, L. Liu, E. Theodoratou, J. Car, and et al. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis Lancet 381 9882 2013 2016 2023
5. Y. Chen, K. Zhou, R. Wang, Y. Liu, Y.D. Kwak, T. Ma, and et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription Proceedings of the National Academy of Sciences of the United States of America 106 10 2009 3907 3912
6. P.Y. Cheng, H.N. Sy, S.L. Wu, W.F. Wang, and Y.Y. Chen Newly diagnosed type 2 diabetes and risk of dementia: a population-based 7-year follow-up study in Taiwan Journal of Diabetes and its Complications 26 5 2012 382 387
7. W.C. Chiu, W.C. Ho, M.H. Lin, H.H. Lee, Y.C. Yeh, J.D. Wang, and et al. Angiotension receptor blockers reduce the risk of dementia Journal of Hypertension 32 4 2014 938 947
8. T.B. Cumming, and A. Brodtmann Can stroke cause neurodegenerative dementia? International Journal of Stroke 6 5 2011 416 424
9. S.M. de la Monte Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease Drugs 72 1 2012 49 66
10. T. Etgen, M. Chonchol, H. Forstl, and D. Sander Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis American Journal of Nephrology 35 5 2012 474 482
11. M. Fei, Z. Yan Ping, M. Ru Juan, L. Ning Ning, and G. Lin Risk factors for dementia with type 2 diabetes mellitus among elderly people in China Age Ageing 42 3 2013 398 400
12. H.H. Feldman, C. Jacova, A. Robillard, A. Garcia, T. Chow, M. Borrie, and et al. Diagnosis and treatment of dementia: 2. Diagnosis CMAJ: Canadian Medical Association journal 178 7 2008 825 836
13. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, and et al. Global prevalence of dementia: a Delphi consensus study Lancet 366 9503 2005 2112 2117
14. L. Frolich, D. Blum-Degen, H.G. Bernstein, S. Engelsberger, J. Humrich, S. Laufer, and et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease Journal of Neural Transmission 105 4-5 1998 423 438
15. I.M. Hajjar, M. Keown, P. Lewis, and A. Almor Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study American Journal of Alzheimer's Disease and Other Dementias 23 1 2008 77 83
16. D.B. Hogan, P. Bailey, S. Black, A. Carswell, H. Chertkow, B. Clarke, and et al. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia CMAJ: Canadian Medical Association journal 179 10 2008 1019 1026
17. C.C. Hsu, M.L. Wahlqvist, M.S. Lee, and H.N. Tsai Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin Journal of Alzheimer's Disease 24 3 2011 485 493
18. M.D. Hurd, P. Martorell, A. Delavande, K.J. Mullen, and K.M. Langa Monetary costs of dementia in the United States New England Journal of Medicine 368 14 2013 1326 1334
19. P. Imfeld, M. Bodmer, S.S. Jick, and C.R. Meier Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study Journal of the American Geriatrics Society 60 5 2012 916 921
20. Y.D. Jiang, C.H. Chang, T.Y. Tai, J.F. Chen, and L.M. Chuang Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database Journal of the Formosan Medical Association 111 11 2012 599 604
21. B.N. Justin, M. Turek, and A.M. Hakim Heart disease as a risk factor for dementia Clinical Epidemiology 5 2013 135 145
22. K. Katsumori, T. Wasada, H. Kuroki, H. Arii, A. Saeki, K. Aoki, and et al. Prevalence of macro- and microvascular diseases in non-insulin-dependent diabetic and borderline glucose-intolerant subjects with insulin resistance syndrome Diabetes Research and Clinical Practice 29 3 1995 195 201
23. S.W. Lai, C.H. Lin, K.F. Liao, L.T. Su, F.C. Sung, and C.C. Lin Association between polypharmacy and dementia in older people: a population-based case-control study in Taiwan Geriatrics and Gerontology International 12 3 2012 491 498
24. A.J. Larner Neurological update: dementia Journal of Neurology 261 3 2014 635 639
25. J.A. Luchsinger Diabetes, related conditions, and dementia Journal of the Neurological Sciences 299 1-2 2010 35 38
26. N. Maroz, and M.S. Segal Lupus nephritis and end-stage kidney disease American Journal of the Medical Sciences 346 4 2013 319 323
27. P. Nderitu, L. Doos, P.W. Jones, S.J. Davies, and U.T. Kadam Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review Family Practice 30 3 2013 247 255
28. M. Pasi, A. Poggesi, E. Salvadori, and L. Pantoni Post-stroke dementia and cognitive impairment Frontiers of Neurology and Neuroscience 30 2012 65 69
29. I.O. Poon Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment Pharmacotherapy 28 3 2008 366 375
30. M. Prince, R. Bryce, E. Albanese, A. Wimo, W. Ribeiro, and C.P. Ferri The global prevalence of dementia: a systematic review and metaanalysis Alzheimers Dement 9 1 2013 63 e75 (e62)
31. C. Qiu, B. Winblad, A. Marengoni, I. Klarin, J. Fastbom, and L. Fratiglioni Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study Archives of Internal Medicine 166 9 2006 1003 1008
32. B. Reed, S. Villeneuve, W. Mack, C. DeCarli, H.C. Chui, and W. Jagust Associations between serum cholesterol levels and cerebral amyloidosis JAMA Neurology 71 2 2014 195 200
33. J.P. Ryan, D.F. Fine, and C. Rosano Type 2 diabetes and cognitive impairment: contributions from neuroimaging Journal of Geriatric Psychiatry and Neurology 27 1 2014 47 55
34. Y. Sasaki, R. Marioni, M. Kasai, H. Ishii, S. Yamaguchi, and K. Meguro Chronic kidney disease: a risk factor for dementia onset: a population-based study. The Osaki-Tajiri Project Journal of the American Geriatrics Society 59 7 2011 1175 1181
35. S.I. Sharp, D. Aarsland, S. Day, H. Sonnesyn, and C. Ballard Hypertension is a potential risk factor for vascular dementia: systematic review International Journal of Geriatric Psychiatry 26 7 2011 661 669
36. I. Skoog, and D. Gustafson Update on hypertension and Alzheimer's disease Neurological Research 28 6 2006 605 611
37. M. Stefani, and G. Liguri Cholesterol in Alzheimer's disease: unresolved questions Current Alzheimer Research 6 1 2009 15 29
38. S. Tanaka, S. Tanaka, S. Iimuro, H. Yamashita, S. Katayama, Y. Akanuma, and et al. Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine Diabetes Care 36 5 2013 1193 1199
39. K.C. Wang, L.C. Woung, M.T. Tsai, C.C. Liu, Y.H. Su, and C.Y. Li Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study Neuroepidemiology 38 4 2012 237 244
40. L.D. Xiao, J. Wang, G.P. He, A. De Bellis, J. Verbeeck, and H. Kyriazopoulos Family caregiver challenges in dementia care in Australia and China: a critical perspective BMC Geriatrics 14 2014 6